
Please try another search
Cigna Corp. (NYSE:CI) has announced that it will buy Express Scripts Holding Co., (NASDAQ:ESRX) a pharmacy benefits provider and other medical servcies.
The deal, valued $67 billion, will be financed by a mix of cash and debt. It will be one of the biggest deals for Cigna.
What’s in the Offing for Cigna?
The deal is expected to be mutually beneficial, given that it would lead to a solid combination of Cigna’s strong position and expertise in the health benefits space with Express Scripts’ leading position in the pharmacy benefits market (PBM).
This combined entity would create a mammoth healthcare set-up with wide-ranging operations from sale of drugs to insurance cover.
The deal will add to Cigna’s scale and size and equip it to negotiate with drug manufacturers and pharmacies better. This would lower the cost of acquiring prescription drugs, enabling the company to share the savings in with its consumers by way of more customer-friendly insurance plans like enhanced frills or lower premium, thus ultimately leading to market-share gains.
Odds of the deals getting a clearance from regulators seem high, as it will be a vertical integration. Last year, Cigna’s merger with Anthem Inc. (NYSE:ANTM) was blocked by regulators last year, on concerns that the combination would stifle competition in the healthcare industry since both companies had overlapping businesses.
In a year’s time shares of the company have gained 28% compared with the industry’s growth of 8.2%.
Moreover, insurers seek an attractive business opportunity in the PBM market, which largely benefits from an aging population, which depends largely on drugs and pharmacy benefit plans. Per a report by Technavio, nearly 14.4% of the U.S. population is aged 65 years and above, which buoys optimism.
Many analysts believe that rising expenditure on prescription drugs and growing demand for specialty drugs have also been strengthening the PBM market. The Centers for Medicare and Medicaid Services report published by Advisory Board predicts the continuation of this trend. Per the report, prescription drug spending is projected to grow roughly 7% between 2018 and 2019.
Consolidation in Healthcare
Most economists believe this coming together of two different industries in the healthcare sector will add a new dimension and might help in checking soaring costs.
Moreover, necessitated by the need of the players to gain in scale and size to weather the changes taking place within the industry, mergers and acquisitions (both horizontal and vertical) are common. No matter whether a company wishes to grow horizontally (expand in the existing business) or vertically (expand into new business), the most sought-after way is to acquire the best fit.
Cigna carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
The Hottest Tech Mega-Trend of All
Last year, it generated $8 billion in global revenues. By 2020, it's predicted to blast through the roof to $47 billion. Famed investor Mark Cuban says it will produce "the world's first trillionaires," but that should still leave plenty of money for regular investors who make the right trades early.
See Zacks' 3 Best Stocks to Play This Trend >>
Since the Robotaxi event on October 11th, Tesla (NASDAQ:TSLA) stock is up 38%, currently priced at $291.60 per share This is a return to the early November 2024 price level. But...
The Q4 2024 earnings season tapers off from here, with S&P 500® EPS growth surpassing 17%, the highest in 3 years Large cap outlier earnings dates this week include:...
Shares of Alibaba (NYSE:BABA) are on a tear to start off 2025. The consumer discretionary and tech stock is up by 52% this year as of the Feb. 25 close. The company’s cloud...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review
Add a Comment
We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.